{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:20:59Z","timestamp":1761718859332,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T00:00:00Z","timestamp":1568419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T00:00:00Z","timestamp":1568419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13730-019-00416-1","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T15:02:26Z","timestamp":1568473346000},"page":"6-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Regression of renal amyloid deposits by VAD therapy plus autologous stem cell transplantation in a patient with primary AL amyloidosis"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3712-6331","authenticated-orcid":false,"given":"Naoya","family":"Toriu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikako","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ikuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinari","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Hayami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenmei","family":"Takaichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Wake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,14]]},"reference":[{"issue":"1","key":"416_CR1","doi-asserted-by":"publisher","first-page":"e2018022","DOI":"10.4084\/mjhid.2018.022","volume":"10","author":"P Milani","year":"2018","unstructured":"Milani P, et al. Light chain amyloidosis. Mediterr J Hematol Infect Dis. 2018;10(1):e2018022.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"12","key":"416_CR2","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1681\/ASN.2006050460","volume":"17","author":"LM Dember","year":"2006","unstructured":"Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol. 2006;17(12):3458\u201371.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"416_CR3","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2215\/CJN.10491012","volume":"8","author":"SM Said","year":"2013","unstructured":"Said SM, Sethi S, Valeri AM, et al. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol. 2013;8(9):1515\u201323.","journal-title":"Clin J Am Soc Nephrol"},{"key":"416_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2369-13-118","volume":"13","author":"T Kuroda","year":"2012","unstructured":"Kuroda T, Tanabe N, Kobayashi D, et al. Significant association between renal function and amyloid-positive area in renal biopsy specimens in AL amyloidosis. BMC Nephrol. 2012;13:118.","journal-title":"BMC Nephrol"},{"issue":"10038","key":"416_CR5","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"AD Wechalekar","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet (London, England). 2016;387(10038):2641\u201354.","journal-title":"Lancet (London, England)"},{"issue":"3","key":"416_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/ki.2012.414","volume":"83","author":"SH Nasr","year":"2013","unstructured":"Nasr SH, Said SM, Valeri AM, et al. The diagnosis and characteristics of renal heavy-chain and heavy\/light-chain amyloidosis and their comparison with renal light-chain amyloidosis. Kidney Int. 2013;83(3):463\u201370.","journal-title":"Kidney Int"},{"issue":"1","key":"416_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2169\/internalmedicine.42.72","volume":"42","author":"T Gono","year":"2003","unstructured":"Gono T, Matsuda M, Dohi N, et al. Nephrotic syndrome due to primary AL amyloidosis, successfully treated with VAD and subsequent high-dose melphalan followed by autologous peripheral blood stem cell transplantation. Intern Med. 2003;42(1):72\u20137.","journal-title":"Intern Med"},{"issue":"5","key":"416_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2141.2004.05232.x","volume":"127","author":"JB Perz","year":"2004","unstructured":"Perz JB, Schonland SO, Hundemer M, et al. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study. Br J Haematol. 2004;127(5):543\u201351.","journal-title":"Br J Haematol"},{"issue":"11","key":"416_CR9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa070484","volume":"357","author":"A Jaccard","year":"2007","unstructured":"Jaccard A, Moreau P, Leblond V, et al. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. NEJM. 2007;357(11):1083\u201393.","journal-title":"NEJM"},{"issue":"12","key":"416_CR10","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.2215\/CJN.02890310","volume":"5","author":"S Sethi","year":"2010","unstructured":"Sethi S, Theis JD, Leung N, et al. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol. 2010;5(12):2180\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"16","key":"416_CR11","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1182\/blood-2011-01-330738","volume":"118","author":"MT Cibeira","year":"2011","unstructured":"Cibeira MT, Sanchorawala V, Seldin DC, et al. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011;118(16):4346\u201352.","journal-title":"Blood"},{"issue":"3","key":"416_CR12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ekir.2017.11.017","volume":"3","author":"P Milani","year":"2018","unstructured":"Milani P, Merlini G, Palladini G. Novel therapies in light chain amyloidosis. Kidney Int Rep. 2018;3(3):530\u201341.","journal-title":"Kidney Int Rep"},{"issue":"5","key":"416_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1136\/thx.54.5.444","volume":"54","author":"JD Gillmore","year":"1999","unstructured":"Gillmore JD, Hawkins PN. Amyloidosis and the respiratory tract. Thorax. 1999;54(5):444\u201351.","journal-title":"Thorax"},{"issue":"4","key":"416_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2141.2010.08503.x","volume":"153","author":"N Katoh","year":"2011","unstructured":"Katoh N, Matsuda M, Tsuchiya-Suzuki A, et al. Regression of gastroduodenal amyloid deposition in systemic AL amyloidosis after intensive chemotherapies. Br J Haematol. 2011;153(4):535\u20138.","journal-title":"Br J Haematol"},{"issue":"2","key":"416_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ki.1994.42","volume":"45","author":"JR Couchman","year":"1994","unstructured":"Couchman JR, Beavan LA, McCarthy KJ. Glomerular matrix: synthesis, turnover and role in mesangial expansion. Kidney Int. 1994;45(2):328\u201335.","journal-title":"Kidney Int"},{"issue":"5","key":"416_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s10157-009-0198-y","volume":"13","author":"O Yamazaki","year":"2009","unstructured":"Yamazaki O, Ubara Y, Suwabe T, et al. Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation. J Clin Exp Nephrol. 2009;13(5):522\u20135.","journal-title":"J Clin Exp Nephrol"},{"issue":"5","key":"416_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2169\/internalmedicine.9263-17","volume":"57","author":"D Iwadate","year":"2018","unstructured":"Iwadate D, Hasegawa E, Hoshino J, et al. The long-term outcomes after VAD plus SCT therapy in a patient with AL amyloidosis and severe factor X deficiency. Intern Med. 2018;57(5):701\u20136.","journal-title":"Intern Med"},{"issue":"3","key":"416_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5414\/CNP63215","volume":"63","author":"M Nakayama","year":"2005","unstructured":"Nakayama M, Kashiwagi M, Katafuchi R, et al. Resolution of primary amyloidosis by melphalan and prednisolone: a case report. Clin Nephrol. 2005;63(3):215\u201320.","journal-title":"Clin Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-019-00416-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-019-00416-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-019-00416-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T09:31:48Z","timestamp":1600075908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-019-00416-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,14]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1007\/s13730-019-00416-1","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2019,9,14]]},"assertion":[{"value":"11 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors also declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The present study adhered to the Declaration of Helsinki and the patient gave written consent for the details of her case to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}